ARKG241115C24500
- 0.17
- -1.83-91.50%
ARK Genomic Revolution ETF Newsroom
Gilead, Vertex Initiated as New Big Biotech Buys at Citi
SoundHound AI Plunges Despite Reporting Record Quarterly Revenue
ARKK's Holdings Ranked by SA Quant Grades
10 Health Care Stocks Whale Activity In Today's Session
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
Donald Trump Victory Week (Nov 4-8): These Large Cap Stocks Were Biggest Gainers
CRISPR, Beam, Other Gene Editing Names up Significantly
Trending Industry Today: ARK Innovation ETF Leads Gains In ARK ETFs Stocks
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
9 Analysts Have This To Say About Intellia Therapeutics
Tempus Announces Publication Of Its Study, "Actionable Structural Variant Detection Via RNA-NGS And DNA-NGS In Patients With Advanced Non-small Cell Lung Cancer," In Jama Network Open
Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Nvidia To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Monday
Tempus AI Analyst Ratings
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
Tempus AI, Inc. (TEM) Q3 2024 Earnings Call Transcript Summary
Sony Posts Upbeat Earnings, Joins Tesla, Upstart, Doximity, Fortrea, Axon Enterprise And Other Big Stocks Moving Higher On Friday
Barclays Maintains Overweight on Intellia Therapeutics, Lowers Price Target to $55
Tempus AI Reports Q3 Results
Adaptive Biotechnologies Corporation (ADPT) Q3 2024 Earnings Call Transcript Summary